Change in disability in patients with multiple sclerosis: a 20-year prospective population-based analysis

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 79, Issue 10, 2008, Pages 1137-1143

  Hirst, C ^a   Ingram, G ^a   Swingler, R ^b   Compston, D A S ^c   Pickersgill, T ^a   Robertson, N P ^a  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^b NINEWELLS HOSPITAL   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL DECISION MAKING; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED STUDY; DISABILITY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIPLE SCLEROSIS; OUTCOME ASSESSMENT; POPULATION RESEARCH; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RATING SCALE; SCORING SYSTEM;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; DISABILITY EVALUATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 53149138584     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2007.133785     Document Type: Article

References (46)

1. Bronnum-Hansen H, Koch-Henriksen N, Hyilested K. Survival of patients with multiple sclerosis in Denmark: a nationwide, long-term epidemiologic survey. Neurology 1994;44:1901-7.
2. Poser S, Kurtzke JF, Poser W, et al. Survival in multiple sclerosis. J Clin Epidemiol 1989;42:159-68.
3. Kantarci O, Siva A, Eraksov M, et al. Survival and predictors of disability in Turkish MS patients. Turkish Multiple Sclerosis Study Group (TUMSSG). Neurology 1998;51:765-72.
4. Pekmezovic T, Jarebinski M, Drulovic J. et al. Survival of multiple sclerosis patients in the Belgrade population. Neuroepidemiology 2002;21:235-40.
5. Amato MP, Ponziani G. Bartolozzi ML, et al. A prospective study on the natural history of multiple sclerosis: clues to the conduct and interpretation of clinical trials. J Neurot Sci 1999;168:96-106.
6. Bronnum-Hansen H, Koch-Henriksen N. Stenager E. Trends in survival and cause of death in Danish patients with multiple sclerosis. Brain 2004;127:844-50.
7. Confavreux C, Aimard G. Devic M. Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients. Brain 1980;103:281-300.
8. Confavraux C, Vukusic S. Accumulation of irreversible disability in multiple sclerosis: from epidemiology to treatment. Clin Neurol Neurosurg 2006;108:327-32.
9. Kremenchutzky M, Rice GP, Baskerville J, et al. The natural history of multiple sclerosis: a geographically based study 9: observations on the progressive phase of the disease. Brain 2006;129:584-94.
10. Phadke JG. Clinical aspects of multiple sclerosis in north-east Scotland with particular reference to its course and prognosis. Brain 1990;113:1597-628.
11. Phadke JG. Survival pattern and cause of death in patients with multiple sclerosis: results from an epidemiological survey in north east Scotland. J Neurol Neurosurg Psychiatry 1987;50:523-31.
12. Pittock SJ, Mayr WT, McClelland RL, et al. Change in MS-related disability in a population-based cohort: a 10-year follow-up study. Neurology 2004;62:51-9.
13. Runmarker B, Andersen O. Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up. Brain 1993;116:117-34.
14. Wallin MT, Page WF, Kurtzke JF. Epidemiology of multiple sclerosis in US veterans VIII. Long-term survival after onset of multiple sclerosis. Brain 2000;123:1677-87
15. Weinshenker BG, Bass B, Rice GP, et al. The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of the early clinical course. Brain 1989;112:1419-28.
16. Weinshenker BG, Bass B, Rice GP, et al. The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. Brain 1989;112:133-46.
17. Weinshenker BG, Issa M, Baskerville J. Long-term and short-term outcome of multiple sclerosis: a 3-year follow-up study. Arch Neurol 1996;53:353-8.
18. Weinshenker BG, Rice GP, Noseworthy JH, et al. The natural history of multiple sclerosis: a geographically based study. 3. Multivariate analysis of predictive factors and models of outcome. Brain 1991;114:1045-56.
19. Weinshenker BG, Rice GP, Noseworthy JH, et al. The natural history of multiple sclerosis: a geographically based study. 4. Applications to planning and interpretation of clinical therapeutic trials. Brain 1991:114:1057-67.
20. Benedikz J, Stefansson M. Guomundsson J, et al. The natural history of untreated multiple sclerosis in Iceland. A total population-based 50 year prospective study. Clin Neurol Neurosurg 2002;104:208-10.
21. Allison RS. Survival in disseminated sclerosis: a clinical study of a series of cases first seen 20 years ago. Brain 1950;73:103- 20.
22. Hawkins SA, McDonnell GV. Benign multiple sclerosis? Clinical course, long term follow up, and assessment of prognostic factors. J Neurol Neurosurg Psychiatry 1999;67:148-52.
23. Mc Alpine D, Compston N. Some aspects of the natural history of disseminated sclerosis. Q J Med 1952;21:135-67.
24. Miller D, Barkhof F, Montalban X, et al. Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis. Lancet Neurol 2005;4:281-8.
25. Leibowitz U, Kahana E, Alter M. Survival and death in multiple sclerosis. Brain 1969;92:115-30.
26. Hyllested K. Lethality, duration, and mortality of disseminated sclerosis in Denmark. Acta Psychiatr Scand 1961;36:553-64.
27. Mylir KM. Riise T, Vedeler C, et al. Disability and prognosis in multiple sclerosis: demographic and clinical variables important for the ability to walk and awarding of disability pension. Mult Scler 2001;7:59-65.
28. Visscher BR, Liu KS, Clark VA, et al. Onset symptoms as predictors of mortality and disability in multiple sclerosis. Acta Neurol Scand 1984;70:321-8.
29. Bergamaschi R, Montomoli C, Candeloro E, et al. Disability and mortality in a cohort of multiple sclerosis patients: a reappraisal. Neuroepidemiology 2005;25:15-8.
30. Citterio A, Azan G, Bergamaschi R, et al. Multiple sclerosis: disability and mortality in a cohort of clinically diagnosed patients. Neuroepidemiology 1989;8:249-53.
31. Levic ZM, Dujmovic I, Pekmezovic T, et al. Prognostic factors for survival in multiple sclerosis. Mult Scler 1999;5:171-8.
32. Poser S, Poser W, Schlaf G, et al. Prognostic indicators in multiple sclerosis. Acta Neurol Scand 1986;74:387-92.
33. Tremlett H, Paty D, Devonshire V. Disability progression in multiple sclerosis is slower than previously reported. Neurology 2006;66:172-7.
34. Troiano M, Avolio C, Manzari C, et al. Multivariate analysis of predictive factors of multiple sclerosis course with a validated method to assess clinical events. J Neurol Neurosurg Psychiatry 1995;58:300-6.
35. Swingler RJ, Compston DA. The prevalence of multiple sclerosis in south east Wales. J Neurol Neurosurg Psychiatry 1988;51:1520-4.
36. Poser CM, Paty DW. Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-31.
37. Government Actuary's Department Historic interim life tables. 2006.
38. Confavreux C, Vukusic S, Moreau T. et al. Relapses and progression of disability in multiple sclerosis. N Engl J Med 2000;343:1430-8.
39. Coles AJ, Cox A, Le Page E, et al. The window of therapeutic opportunity in multiple sclerosis Evidence from monoclonal antibody therapy. J Neurol 2006;253:98-108.
40. Thompson AJ, Hutchinson M. Brazil J, et al. A clinical and laboratory study of benign multiple sclerosis. Q J Med 1986;58:69-80.
41. Roberts MH, Martin JP, McLellan DL, et al. The prevalence of multiple sclerosis in the Southampton and South West Hampshire Health Authority. J Neurol Neurosurg Psychiatry 1991;54:55-9.
42. Mumford CJ, Fraser MB, Wood NW, et al. Multiple sclerosis in the Cambridge health district of east Anglia. J Neurol Neumsurg Psychiatry 1992;55:877-82.
43. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 2005;58:840-6.
44. Roxburgh RH, Seaman SR, Masterman T, et al. Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity. Neurology 2005;64:1144-51.
45. Pittock SJ, McClelland RL, Mayr WT, et al. Clinical implications of benign multiple sclerosis: a 20-year population-based follow-up study. Ann Neurol 2004;56:303-6.
46. Sayao AL, Devonshire V, Tremlett H. Longitudinal follow-up of "benign" multiple sclerosis at 20 years. Neurology 2007;68:496-500.